Litigation and regulatory developments related to PFAS continue to expand, exposing an increasing number of industries and companies to various risks Companies should assess the potential impact of ...

With evolving regulations and emerging risks—including tariffs, DEI-related controversies, and cybersecurity concerns—some public companies are refining their approach to assessing and updating risk ...

The Lancet Commission has declared obesity a disease. With enough controversy to fill a buffet table, their new definition is sparking heated debates in science, media, and beyond. But does this ...